Capstone Investment Advisors
XENT

Capstone Investment Advisors’s Intersect ENT, Inc XENT Stock Holding History

Capstone Investment Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-120,855
Closed -$3.38M – 2214
2022
Q1 		$3.38M Buy
120,855
+25,526
+27% +$700K 0.01% 847
2021
Q4 		$2.6M Sell
95,329
-31,092
-25% -$843K ﹤0.01% 1042
2021
Q3 		$3.44M Buy
+126,421
New +$3.13M 0.01% 987

Capstone Investment Advisors's XENT Position: Q2 2022 in Review

Capstone Investment Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 120,855 shares — an estimated $3.38M sold.

Capstone Investment Advisors first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $3.44M in Q3 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Capstone Investment Advisors reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Capstone Investment Advisors sold 120,855 Intersect ENT, Inc shares in Q2 2022, an estimated $3.38M.
  • Capstone Investment Advisors first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
  • Capstone Investment Advisors's Intersect ENT, Inc position peaked at $3.44M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Capstone Investment Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.